Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Mar;74(3):312-8.
doi: 10.1111/j.1365-2265.2010.03919.x.

Mutational analysis of PHEX, FGF23 and DMP1 in a cohort of patients with hypophosphatemic rickets

Affiliations

Mutational analysis of PHEX, FGF23 and DMP1 in a cohort of patients with hypophosphatemic rickets

Mary D Ruppe et al. Clin Endocrinol (Oxf). 2011 Mar.

Abstract

Background: X-linked hypophosphatemic rickets, autosomal dominant hypophosphatemic rickets and autosomal recessive hypophosphatemic rickets make up a group of renal phosphate wasting disorders with common clinical and biochemical characteristics. These three types of rickets are related to mutations in PHEX, FGF23 and dentin matrix protein 1 (DMP1), respectively.

Objective: The objective of the study was to evaluate the frequency of mutations that occur in these three genes associated with hypophosphatemic rickets.

Patients and methods: In this study, we sequenced these genes in 76 members of 46 kindreds from a large hypophosphatemic rickets cohort.

Results: Forty-two individuals from 27 kindreds were found to have mutations in PHEX; 16 of which were novel. One subject had an FGF23 mutation. No individuals were found to have mutations in DMP1 consistent with the presence of recessive hypophosphatemic rickets.

Conclusions: Our data highlight the wide spectrum of genetic variation that can be seen in PHEX, FGF23 and DMP1 when screening a large cohort with hypophosphatemic rickets.

PubMed Disclaimer

Conflict of interest statement

Competing interests/financial disclosure

None to declare.

References

    1. Albright F, Butler A, Bloomberg E. Rickets Resistant to Vitamin D Therapy. Am J Dis Child. 1939;54:529–547.
    1. Davies M, Stanbury SW. The rheumatic manifestations of metabolic bone disease. Clinics in Rheumatic Diseases. 1981;7:595–646.
    1. Beck-Nielsen SS, Brock-Jacobsen B, Gram J, et al. Incidence and prevalence of nutritional and hereditary rickets in southern Denmark. European Journal of Endocrinology/European Federation of Endocrine Societies. 2009;160:491–497. - PubMed
    1. A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. The HYP Consortium. Nature Genetics. 1995;11:130–136. - PubMed
    1. Beck L, Soumounou Y, Martel J, et al. Pex/PEX tissue distribution and evidence for a deletion in the 3′ region of the Pex gene in X-linked hypophosphatemic mice. Journal of Clinical Investigation. 1997;99:1200–1209. - PMC - PubMed

Publication types